NICE Type 2 Diabetes Guidelines: What you need to know about the update
The session will be delivered by a member of the committee that developed the recent ‘Type 2 diabetes in adults: management’ NICE guideline [NG28]. The session will offer insight into what has changed, specifically the focus on cardiovascular disease assessment, medicines optimisation and shared decisions making as a key message. The session will further consider the implications for practice for the patient and clinicians. The session will help pharmacists to understand how they can be part of the diabetes care and support the person living with diabetes.